Coronavirus News and Research

RSS

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

World Health Organization (WHO) guidelines indicate the optimal timing of vaccination among specific groups based on the probability of infection and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), e.g., health care workers providing direct care or acute disease and death (e.g., older people, organ transplant recipients).

11 Aug 2021

A new promising target for broad-spectrum therapeutics against coronaviruses

A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.

11 Aug 2021

COVID-19 booster shot in autumn will effectively protect against existing and future variants

Scientists at the University of Nottingham have confirmed that an autumn 'booster' dose of a Covid-19 vaccine will be an effective way to protect people from existing, and potentially future, variants of concern.

11 Aug 2021

COVID-19 vaccines offer better protection than natural immunity alone

Now, the U.S. Centers for Disease Control and Prevention (CDC) reports that among people who were previously infected with SARS-CoV-2, those who were still unvaccinated are more likely to be reinfected than those fully vaccinated after prior infection.

11 Aug 2021

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Scientists from Germany and Belgium have recently described the immunogenicity of a plant-based virus-like particle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine induces robust antibody and T cell responses for at least 6 months. Moreover, the vaccine demonstrates potent neutralizing efficacy against the B.1.1.7, B.1.351, and P1 variants of SARS-CoV-2.

11 Aug 2021

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

A new study demonstrates that the two mRNA vaccines have widely varying efficacies against the SARS-CoV-2 Delta variant.

10 Aug 2021

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

A new study explores the polyclonal antibody response to SARS-CoV-2 in greater detail.

10 Aug 2021

Green spaces, especially forest, reduce COVID-19 incidence, study says

An intriguing new study reveals that the closer you are to green spaces, especially forests, the less likely you are to be infected with SARS-CoV-2.

10 Aug 2021

Study shows efficacy of gamma irradiation of SARS-CoV-2 vaccine candidate in mouse model

A new study reports a more rapid method of viral inactivation in an effort to increase the appeal of inactivated viral vaccines against the COVID-19 pandemic.

10 Aug 2021

High alcohol consumption increases risk of SARS-CoV-2 infection, finds US student study

A new study finds that heavy alcohol drinking is associated with an increase in the number of COVID-19 cases among American college students.

10 Aug 2021

Natural vs. vaccine-induced COVID-19 immunity

A new paper discusses the protection offered by immunity against COVID-19 following vaccination as compared to natural infection.

10 Aug 2021

Comparative scoring system suggests possibility of global COVID-19 eradication

The global eradication of COVID-19 is probably feasible, and more so than it is for polio, although considerably less so than it was for smallpox, suggests a comparative score of technical, sociopolitical, and economic factors for all three infections, published in the online journal BMJ Global Health.

10 Aug 2021

New platform can quickly identify common mutations on the SARS-CoV-2 virus

Researchers at the University of Colorado Boulder have developed a platform which can quickly identify common mutations on the SARS-CoV-2 virus that allow it to escape antibodies and infect cells.

10 Aug 2021

New optical technique for remote detection of viruses on surfaces

Researchers from the Universidad de Sevilla (University of Seville) have developed and patented a prototype to detect remotely viruses (including synthetic SARS-CoV-2) deposited on surfaces, analyzing images taken at multiple wavelengths - the so-called hyperspectral imaging - a technique commonly used in astrophysics.

10 Aug 2021

Systematic anatomical study specifies guidelines for performing nasopharyngeal swabs

Since the start of the coronavirus pandemic, thousands of nasopharyngeal swabs have been taken in Austria - millions worldwide.

10 Aug 2021

A quarter of US hospitals, and counting, demand workers get vaccinated. But not here.

Hospitals coast to coast are demanding their employees get vaccinated against covid as the highly contagious delta variant tears through populations with low vaccination rates.

10 Aug 2021

Study explores ‘brain fog’ following COVID-19

A recent survey conducted in the United Kingdom revealed that approximately one in every five experiences prolonged coronavirus disease 2019 (COVID-19) symptoms five weeks post-infection. Also, one in seven people reported persistent symptoms even after twelve weeks.

10 Aug 2021

Cardioprotective role of HIF1α in COVID-19 patients

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first emerged in Wuhan, China, in late December 2019, has quickly become the most urgent issue facing scientists worldwide. It has been reported that the respiratory infection causes cardiac dysfunction in 25-55% patients, including hospitalized patients and non-critical patients.

10 Aug 2021

SARS-CoV-2 Iota variant increases mortality risk among older adults

The findings reveal that the variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults. The study is currently available on the medRxiv* preprint server.

10 Aug 2021

SARS-CoV-2 variants and their ability to infect mice

A new study published on the bioRxiv* preprint server has conducted in silico studies along with in vitro, in vivo, and in situ observations and indicated the mouse adaptation of SARS-CoV-2.

10 Aug 2021

Coronavirus News and Research

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

A new promising target for broad-spectrum therapeutics against coronaviruses

COVID-19 booster shot in autumn will effectively protect against existing and future variants

COVID-19 vaccines offer better protection than natural immunity alone

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Green spaces, especially forest, reduce COVID-19 incidence, study says

Study shows efficacy of gamma irradiation of SARS-CoV-2 vaccine candidate in mouse model

High alcohol consumption increases risk of SARS-CoV-2 infection, finds US student study

Natural vs. vaccine-induced COVID-19 immunity

Comparative scoring system suggests possibility of global COVID-19 eradication

New platform can quickly identify common mutations on the SARS-CoV-2 virus

New optical technique for remote detection of viruses on surfaces

Systematic anatomical study specifies guidelines for performing nasopharyngeal swabs

A quarter of US hospitals, and counting, demand workers get vaccinated. But not here.

Study explores ‘brain fog’ following COVID-19

Cardioprotective role of HIF1α in COVID-19 patients

SARS-CoV-2 Iota variant increases mortality risk among older adults

SARS-CoV-2 variants and their ability to infect mice

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News